MiNK Therapeutics, Inc.INKTNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank20
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P20
Within normal range
Average
-536.63%
Historical baseline
PeriodValueYoY Change
20240.00%-
20230.00%-
20220.00%-
20210.00%-
20200.00%+100.0%
2019-3219.79%-